Regenerative medicine is a branch of translational research in tissue engineering and molecular biology which deals with the "process of replacing, engineering or regenerating human or animal cells, tissues or organs to restore or establish normal function". This field holds the promise of engineering damaged tissues and organs by stimulating the body's own repair mechanisms to functionally heal previously irreparable tissues or organs.
Regenerative medicine also includes the possibility of growing tissues and organs in the laboratory and implanting them when the body cannot heal itself. If a regenerated organ's cells would be derived from the patient's own tissue or cells, this would potentially solve the problem of the shortage of organs available for donation, and the problem of organ transplant rejection.
Components of the Book:
- Chapter 1
Transforming healthcare through regenerative medicine
- Chapter 2
De motu cordis: the future of regenerative medicine
- Chapter 3
Fat on sale: role of adipose-derived stem cells as anti-fibrosis agent in regenerative medicine
- Chapter 4
Regenerative medicine in China: demands, capacity, and regulation
- Chapter 5
Functional imaging for regenerative medicine
- Chapter 6
Static magnetic field enhances synthesis and secretion of membrane-derived microvesicles (MVs) rich in VEGF and BMP-2 in equine adipose-derived stromal cells (EqASCs)—a new approach in veterinary regenerative medicine
- Chapter 7
Static Magnetic Field (SMF) as a Regulator of Stem Cell Fate – New Perspectives in Regenerative Medicine Arising from an Underestimated Tool
- Chapter 8
Adipose-derived mesenchymal stem cells from liposuction and resected fat are feasible sources for regenerative medicine
- Chapter 9
Melatonin plays critical role in mesenchymal stem cell-based regenerative medicine in vitro and in vivo
- Chapter 10
Cultured epidermal stem cells in regenerative medicine
- Chapter 11
Is Regenerative Medicine Ready for Prime Time in Diabetic Polyneuropathy?
- Chapter 12
Umbilical cord-derived Wharton’s jelly for regenerative medicine applications
Readership:
Students, academics, teachers and other people attending or interested in Regenerative Medicine
Iain S. Whitaker, Institute of Life Sciences, Swansea University Medical School, Swansea University, Swansea, UK
Manoj K. Gupta, Section of Islet Cell and Regenerative Biology, Joslin Diabetes Center, Harvard Medical School, Boston, USA
Amrendra Kumar Ajay, Renal Division, Department of Medicine, Brigham and Women’s Hospital, Boston, USA
Xiaobing Fu, Chinese Academy of Engineering (Division of Medical and Health), College of Life Sciences, Medical College of PLA, General Hospital of PLA, 28 Fu Xian Road, Beijing, China
Sandra Schneider, Experimental Trauma Surgery, Department of Trauma Surgery, Klinikum rechts der Isar, Technical University of Munich, Germany
Lanjuan Li, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, School of Medicine, First Affiliated Hospital, Zhejiang University, Hangzhou, Zhejiang, China
and more...